Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients (Q47734969)

5 February 2018

title

Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients (English)

1 reference

5 February 2018

author name string

Knobler H

1 reference

5 February 2018

Savion N

1 reference

5 February 2018

Shenkman B

1 reference

5 February 2018

Kotev-Emeth S

1 reference

5 February 2018

Varon D

1 reference

5 February 2018

publication date

1 May 1998

1 reference

5 February 2018

published in

Thrombosis Research

1 reference

5 February 2018

volume

1 reference

5 February 2018

issue

1 reference

5 February 2018

page(s)

181-190

1 reference

5 February 2018

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Platelet abnormalities in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Platelet hyperreactivity and prognosis in survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Can restenosis after coronary angioplasty be predicted from clinical variables?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Potential mechanisms promoting restenosis in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Increased Platelet Aggregation in Early Diabetus Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Platelet function in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Thromboxane biosynthesis and platelet function in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Evaluation of the clinical utility of platelet aggregation studies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Do platelets have anything to do with diabetic microvascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

The influence of lipoproteins on blood platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Platelet lipoprotein interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Effects of dietary and pharmacologic alteration of serum lipids on platelet survival time

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

The effect of antihypertensive drugs on in vivo platelet activity in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900050-4

7 January 2021

10.1016/S0049-3848(98)00050-4

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018